Matsunaga, H.; Takeuchi, H.; Oba, Y.; Fujimi, S.; Honda, T.; Tomonaga, K.
Waning of Anti-SARS-CoV-2 Spike Antibody Levels 100 to 200 Days after the Second Dose of the BNT162b2 Vaccine. Vaccines 2022, 10, 177.
https://doi.org/10.3390/vaccines10020177
AMA Style
Matsunaga H, Takeuchi H, Oba Y, Fujimi S, Honda T, Tomonaga K.
Waning of Anti-SARS-CoV-2 Spike Antibody Levels 100 to 200 Days after the Second Dose of the BNT162b2 Vaccine. Vaccines. 2022; 10(2):177.
https://doi.org/10.3390/vaccines10020177
Chicago/Turabian Style
Matsunaga, Hidenori, Hidefumi Takeuchi, Yuichiro Oba, Satoshi Fujimi, Tomoyuki Honda, and Keizo Tomonaga.
2022. "Waning of Anti-SARS-CoV-2 Spike Antibody Levels 100 to 200 Days after the Second Dose of the BNT162b2 Vaccine" Vaccines 10, no. 2: 177.
https://doi.org/10.3390/vaccines10020177
APA Style
Matsunaga, H., Takeuchi, H., Oba, Y., Fujimi, S., Honda, T., & Tomonaga, K.
(2022). Waning of Anti-SARS-CoV-2 Spike Antibody Levels 100 to 200 Days after the Second Dose of the BNT162b2 Vaccine. Vaccines, 10(2), 177.
https://doi.org/10.3390/vaccines10020177